Rabeprazole sodium delayed-release tablets are indicated for short-term (4 to 8 weeks) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (gerd) for those patients who have not healed after 8 weeks of treatment, an additional 8-week course of rabeprazole sodium delayed-release tablets may. Gerd medication rabeprazole. Gerd and rabeprazole abstract & commentary by malcolm robinson md, facp, facg, emeritus clinical professor of medicine, university of oklahoma college of medicine, oklahoma city dr robinson serves as a consultant for tap, pfizer, janssen, eisai, j&j-merck, and procter & gamble, is on the speaker's bureau of janssen, eli lilly, solvay, tap, and aventis, and does research for forest labs.
gerd medication rabeprazole
